PA8805501A1 - Uso de la mequitazina en forma de racemato o de enantiómeros para la preparacion de un medicamento destinado al tratamiento o a la prevencion de patologias que implican los receptores histamínicos h4 - Google Patents
Uso de la mequitazina en forma de racemato o de enantiómeros para la preparacion de un medicamento destinado al tratamiento o a la prevencion de patologias que implican los receptores histamínicos h4Info
- Publication number
- PA8805501A1 PA8805501A1 PA20088805501A PA8805501A PA8805501A1 PA 8805501 A1 PA8805501 A1 PA 8805501A1 PA 20088805501 A PA20088805501 A PA 20088805501A PA 8805501 A PA8805501 A PA 8805501A PA 8805501 A1 PA8805501 A1 PA 8805501A1
- Authority
- PA
- Panama
- Prior art keywords
- histaminal
- receivers
- preparation
- pathologies
- medicinal product
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE AL USO DE LA 10-[(3R)-1-AZABICICLO[2.2.2]OCT-3-ILMETIL]-10H-FENOTIAZINA,DE LA 10-[(3S)-1-AZABICICLO[2.2.2.]OCT-3-ILMETIL]-10 H-FENOTIAZINA O DE LA 10-[(3R,3S)-1-AZABICICLO[2.2.2]OCT-3-ILMETIL]-10H-FENOTIAZINA,O BIEN DE UNA DE SUS SALES FARMACÉUTICAMENTE ACEPTABLES PARA LA PREPARACIÓN DE UN MEDICAMENTO DESTINADO A PREVENIR O A TRATAR LAS PATALOGÍAS QUE IMPLICAN LOS RECEPTORES HISTAMÍNICOS H4
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0759538A FR2924344B1 (fr) | 2007-12-04 | 2007-12-04 | Utilisation de la mequitazine sous la forme de racemate ou d'enantiomeres pour la preparation d'un medicament destine au traitement ou a la prevention de pathologies impliquant les recepteurs histaminiques h4. |
| FR0854144A FR2924345B1 (fr) | 2007-12-04 | 2008-06-23 | Utilisation de la mequitazine sous la forme de racemate ou d'enantiomeres pour la preparation d'un medicament destine au traitement ou a la prevention de pathologies impliquant les recepteurs histaminiques h4. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8805501A1 true PA8805501A1 (es) | 2009-12-16 |
Family
ID=39522380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA20088805501A PA8805501A1 (es) | 2007-12-04 | 2008-11-27 | Uso de la mequitazina en forma de racemato o de enantiómeros para la preparacion de un medicamento destinado al tratamiento o a la prevencion de patologias que implican los receptores histamínicos h4 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20100273752A1 (es) |
| EP (2) | EP2255811A1 (es) |
| JP (2) | JP2011505411A (es) |
| KR (1) | KR20100108347A (es) |
| CN (1) | CN101883566B (es) |
| AR (1) | AR070673A1 (es) |
| AU (1) | AU2008333220B2 (es) |
| BR (1) | BRPI0820652A2 (es) |
| CA (1) | CA2706898A1 (es) |
| CL (1) | CL2008003584A1 (es) |
| FR (2) | FR2924344B1 (es) |
| HK (1) | HK1148667A1 (es) |
| IL (1) | IL206073A0 (es) |
| MA (1) | MA31930B1 (es) |
| MX (1) | MX2010006139A (es) |
| NZ (1) | NZ586212A (es) |
| PA (1) | PA8805501A1 (es) |
| RU (1) | RU2510273C2 (es) |
| TN (1) | TN2010000241A1 (es) |
| TW (1) | TW200932242A (es) |
| WO (1) | WO2009071625A1 (es) |
| ZA (2) | ZA201004312B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2201982A1 (en) | 2008-12-24 | 2010-06-30 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Histamine H4 receptor antagonists for the treatment of vestibular disorders |
| EP2858647B1 (en) | 2012-06-08 | 2018-05-23 | Sensorion | H4 receptor inhibitors for treating tinnitus |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2440371A1 (fr) * | 1978-10-31 | 1980-05-30 | Fisons Ltd | Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer |
| FR2522660A1 (fr) * | 1982-03-05 | 1983-09-09 | Pharmuka Lab | Isomere levogyre de la mequitazine, son procede de preparation et medicaments le contenant |
| JPS6330420A (ja) * | 1986-07-25 | 1988-02-09 | Sekisui Chem Co Ltd | 持続性抗アレルギ−固形塗布剤 |
| JP2735122B2 (ja) * | 1988-06-13 | 1998-04-02 | 旭化成工業株式会社 | メキタジンの液状シロップ製剤 |
| IT1251161B (it) * | 1991-08-07 | 1995-05-04 | Derivati ammonio quaternari di (-) e (+)-3-(10 h-fenotiazin-10-ilmetil)-l-azabiciclo (2.2.2.)ottano e composizioni farmaceutiche che li contengono | |
| DE19653969A1 (de) * | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Kg | Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole |
| FR2822709B1 (fr) * | 2001-03-30 | 2007-01-19 | Antialis | Composition pharmaceutique anti-allergique comprenant au moins un allergene et au moins un compose antihistaminique |
| DE10158036B4 (de) * | 2001-11-27 | 2007-05-03 | Kosmas Kg | Antiallergisches Mittel und dessen Verwendung |
| WO2004066960A2 (en) * | 2003-01-28 | 2004-08-12 | Schering Corporation | Combination of h1, h3 and h4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis |
| JP2005060233A (ja) * | 2003-08-08 | 2005-03-10 | Rohto Pharmaceut Co Ltd | 皮膚外用剤 |
| EP1526135A1 (en) * | 2003-10-24 | 2005-04-27 | Warner-Lambert Company LLC | Azabenzodiazepines as pde4 inhibitors |
| WO2005063253A1 (ja) * | 2003-12-26 | 2005-07-14 | Taiho Pharmaceutical Co., Ltd. | アレルギー症状治療用医薬組成物 |
| FR2896690B1 (fr) * | 2006-01-30 | 2008-05-02 | Pierre Fabre Medicament Sa | Utilisation de l'enantiomere(s) de la mequitazine pour la preparation d'un medicament, tout en limitant la toxicite genomique |
-
2007
- 2007-12-04 FR FR0759538A patent/FR2924344B1/fr not_active Expired - Fee Related
-
2008
- 2008-06-23 FR FR0854144A patent/FR2924345B1/fr not_active Expired - Fee Related
- 2008-11-26 TW TW097145696A patent/TW200932242A/zh unknown
- 2008-11-27 PA PA20088805501A patent/PA8805501A1/es unknown
- 2008-12-01 CL CL2008003584A patent/CL2008003584A1/es unknown
- 2008-12-04 CN CN2008801188010A patent/CN101883566B/zh not_active Expired - Fee Related
- 2008-12-04 CA CA2706898A patent/CA2706898A1/en not_active Abandoned
- 2008-12-04 KR KR1020107013817A patent/KR20100108347A/ko not_active Application Discontinuation
- 2008-12-04 BR BRPI0820652A patent/BRPI0820652A2/pt not_active IP Right Cessation
- 2008-12-04 WO PCT/EP2008/066787 patent/WO2009071625A1/en active Application Filing
- 2008-12-04 RU RU2010125711/15A patent/RU2510273C2/ru not_active IP Right Cessation
- 2008-12-04 US US12/746,115 patent/US20100273752A1/en not_active Abandoned
- 2008-12-04 AU AU2008333220A patent/AU2008333220B2/en not_active Ceased
- 2008-12-04 NZ NZ586212A patent/NZ586212A/xx not_active IP Right Cessation
- 2008-12-04 EP EP10177151A patent/EP2255811A1/en not_active Withdrawn
- 2008-12-04 MX MX2010006139A patent/MX2010006139A/es active IP Right Grant
- 2008-12-04 EP EP08856761.5A patent/EP2227235B1/en active Active
- 2008-12-04 AR ARP080105280A patent/AR070673A1/es unknown
- 2008-12-04 JP JP2010536457A patent/JP2011505411A/ja active Pending
-
2010
- 2010-05-28 TN TN2010000241A patent/TN2010000241A1/fr unknown
- 2010-05-30 IL IL206073A patent/IL206073A0/en unknown
- 2010-06-18 ZA ZA2010/04312A patent/ZA201004312B/en unknown
- 2010-06-22 MA MA32940A patent/MA31930B1/fr unknown
- 2010-10-26 ZA ZA2010/07626A patent/ZA201007626B/en unknown
-
2011
- 2011-03-18 HK HK11102709.5A patent/HK1148667A1/xx not_active IP Right Cessation
-
2013
- 2013-12-04 JP JP2013251130A patent/JP2014065726A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TW200932242A (en) | 2009-08-01 |
| CN101883566A (zh) | 2010-11-10 |
| IL206073A0 (en) | 2010-11-30 |
| AR070673A1 (es) | 2010-04-28 |
| FR2924344B1 (fr) | 2010-04-16 |
| EP2255811A1 (en) | 2010-12-01 |
| TN2010000241A1 (en) | 2011-11-11 |
| JP2011505411A (ja) | 2011-02-24 |
| KR20100108347A (ko) | 2010-10-06 |
| FR2924345B1 (fr) | 2010-06-04 |
| RU2510273C2 (ru) | 2014-03-27 |
| WO2009071625A1 (en) | 2009-06-11 |
| CA2706898A1 (en) | 2009-06-11 |
| MA31930B1 (fr) | 2010-12-01 |
| RU2010125711A (ru) | 2012-01-10 |
| NZ586212A (en) | 2012-09-28 |
| AU2008333220B2 (en) | 2014-04-24 |
| FR2924344A1 (fr) | 2009-06-05 |
| ZA201004312B (en) | 2011-02-23 |
| ZA201007626B (en) | 2011-08-31 |
| AU2008333220A1 (en) | 2009-06-11 |
| CL2008003584A1 (es) | 2009-05-22 |
| EP2227235A1 (en) | 2010-09-15 |
| BRPI0820652A2 (pt) | 2019-09-10 |
| FR2924345A1 (fr) | 2009-06-05 |
| JP2014065726A (ja) | 2014-04-17 |
| MX2010006139A (es) | 2010-10-15 |
| CN101883566B (zh) | 2013-03-06 |
| HK1148667A1 (en) | 2011-09-16 |
| US20100273752A1 (en) | 2010-10-28 |
| EP2227235B1 (en) | 2014-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT200600260A (es) | Derivados de benzamida y usos relacionados con los mismos | |
| AR050623A1 (es) | Metodo para el tratamiento del trastorno de hiperactividad de deficit de atencion | |
| ES2531118T3 (es) | Composición farmacéutica que comprende lacosamida y levetiracetamo para uso en el tratamiento de la epilepsia | |
| ECSP077999A (es) | Formulaciones de una sal de bupropion de liberación modificada | |
| GT201100127A (es) | Moduladores de aril metil benzoquinazolinona alostéricos positivos del receptor m1 | |
| BRPI0509184A (pt) | composições farmacêuticas | |
| CR20110110A (es) | Composicion farmaceutica | |
| UY30986A1 (es) | Derivados fluorinados de deferiprona | |
| AR061446A1 (es) | Utilizacion de la 1,7 -dimetilxantina para la fabricacion de un medicamento psicoanaleptico no ansiogeno destinado al tratamiento de un trastorno neuropsiquiatrico | |
| BRPI0817275A2 (pt) | Combinação farmacêutica de alisquireno e valsartana | |
| CL2008000981A1 (es) | Compuestos derivados de imidazolidin-carboxamida; composicion farmaceutica; procedimiento de produccion de la composicion farmaceutica; y uso en el tratamiento y/o prevencion de trastornos ateroscleroticos, de metabolismo de acidos grasos y en los qu | |
| MA31218B1 (fr) | Forme galenique secable permettant une liberation modifiee du principe actif | |
| CL2011002766A1 (es) | Compuestos derivados de carboxamida, inhibidores de calpaina; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades neurodegenerativas, alzahimer, dolor, entre otras. | |
| UY31922A (es) | Compuestos | |
| MX2009004017A (es) | Usos de los compuestos carboxi-amido triazol y sus sales. | |
| CL2008002809A1 (es) | Compuestos derivados de cianoisoquinolina; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de una adiccion a las drogas, en el tratamiento de un trastorno neurodegenerativo, como alzheimer, parkinson, demencia, entre otros. | |
| ECSP10010052A (es) | Formulaciones galenicas de alisquireno y valsartan | |
| HN2003000379A (es) | Derivados de anilinopirazol utiles en el tratamiento de la diabetes | |
| CR20190144A (es) | Compuestos de aza-indazol para usar en lesiones de tendones y/o ligamentos | |
| GT200500328A (es) | Sal l-tartrato de n-1-adamantil-2-{3-[(2r)-2-({(2r)-2-hidroxi-2[4-hidroxi-3-(hidroximetil)fenil]etil}amino)propil]fenil}acetamida. | |
| MX2009011999A (es) | Extruidos con enmascaramiento del sabor mejorado. | |
| UY30029A1 (es) | Derivados de piperidina, sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones | |
| UY31758A (es) | Forma cristalina anhidra de maleato de orvepitant | |
| BR122016006880B8 (pt) | forma de dosagem contendo pantoprazol como ingrediente ativo | |
| PA8805501A1 (es) | Uso de la mequitazina en forma de racemato o de enantiómeros para la preparacion de un medicamento destinado al tratamiento o a la prevencion de patologias que implican los receptores histamínicos h4 |